NASDAQ •
Healthcare •
Medical Devices •
Quote as of 08/25/2026 09:39
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization896.13 mln
Float65.79 mln
Earnings Date11/18/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.98
Likely reliable
Relative Strength
30
/ 100
Underperforming
Debt / Equity
0.01
Debt-free
ROE
-92.83
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Anteris Technologies Global Corp. is an Australian medical device company focused on treating heart valve disease through minimally invasive procedures. Its flagship product, the DurAVR system, uses a catheter to deliver an artificial aortic valve designed to closely replicate how a healthy human valve functions. The company also develops tissue preparation technology that reduces calcium buildup in animal-derived materials used for heart surgery, along with a precision delivery tool that helps surgeons navigate the catheter safely through the heart.
